SCHEMBL24011808

SCHEMBL24011808

CC(C)(C)CCc1cccc(CCC(C)(C)C)c1N1C(=O)c2cc(Oc3ccccc3)c3c4c(Oc5ccccc5)cc5c6c(cc(Oc7ccccc7)c(c7c(Oc8ccccc8)cc(c2c37)C1=O)c64)C(=O)N(c1c(CCC(C)(C)C)cccc1CCC(C)(C)C)C5=O

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 1/20 0.39
▸ ANPEP P15144 2/20 0.35
▸ DPP4 P27487 2/20 0.35
▸ NR1H3 Q13133 5/20 0.33
▸ NR1H2 P55055 3/20 0.33
▸ GRM5 P41594 1/20 0.32
▸ HRH1 P35367 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ ALOX12 P18054 1/20 0.31
▸ FAAH O00519 1/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011917 0.87 ANPEP (0.33) ANPEPDPP4SMN1; SMN2
SCHEMBL24011802 0.83 NR1H2 (0.47) ANPEPDPP4NR1H3NR1H2
SCHEMBL24012195 0.82 ANPEP (0.36) RIPK1ANPEPDPP4GRM5SLC6A2
SCHEMBL24012158 0.82 HCRTR1 (0.36) RIPK1ANPEPDPP4HRH1LMNA
SCHEMBL23772269 0.81 HCRTR1 (0.36) RIPK1HRH1LMNA
SCHEMBL24011922 0.80 ANPEP (0.41) ANPEPDPP4NR1H3NR1H2LMNA
SCHEMBL24012160 0.80 ANPEP (0.38) RIPK1ANPEPDPP4GRM5SLC6A2
SCHEMBL13498707 0.78 DPP4 (0.46) ANPEPDPP4LMNASMN1; SMN2ALOX15
SCHEMBL24011933 0.77 BRD4 (0.37) SMN1; SMN2BRD4MEN1KMT2A
SCHEMBL14309158 0.76 ANPEP (0.43) ANPEPDPP4NR1H3NR1H2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210351356-A1 IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES Konica Minolta, Inc. (JP) 2021-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210351356-A1 IMIDE DERIVATIVE, LUMINESCENT COMPOSITION CONTAINING SAME, LUMINOUS THIN FILM, AND LUMINOUS PARTICLES IGF1R, IK, BMI1 RIPK1 1910/4885ANPEP 4805/4885DPP4 4366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback